Search Within

Marc Ladanyi

Formats
  1. Journal Article (648)
  2. Meeting Abstract (641)
  3. Book Section (13)
  4. Research Letter (8)
  5. Review (7)
  6. Editorial (5)
  7. Guidelines (3)
  8. Conference Paper (1)
  9. Correspondence (1)
  10. Miscellaneous (1)
Groups
  1. Department of Pathology and Laboratory Medicine (1328)
  2. GSK Faculty (1328)
  3. Human Oncology and Pathogenesis Program (1328)
  4. Tow Center for Developmental Oncology (TCDO) (1328)
  5. Department of Medicine (641)
  6. Solid Tumor Oncology Division (612)

More Groups

People
  1. Maria Arcila (300)
  2. Michael Berger (219)
  3. Mark Kris (189)
  4. Gregory Riely (187)
  5. Ahmet Zehir (177)
  6. Natasha Rekhtman (132)

More People

Years
  1. 2025 (15)
  2. 2024 (37)
  3. 2023 (48)
  4. 2022 (72)
  5. 2021 (62)
  6. 2020 (63)

More Years

Publications
  1. Modern Pathology (189)
  2. Laboratory Investigation (153)
  3. Journal of Clinical Oncology (126)
  4. Journal of Molecular Diagnostics (93)
  5. Clinical Cancer Research (86)
  6. Journal of Thoracic Oncology (77)

More Publications

Publishers
  1. Nature Publishing Group (221)
  2. American Association for Cancer Research (201)
  3. Nature Research (191)
  4. American Society of Clinical Oncology (151)
  5. Elsevier Science, Inc. (120)
  6. Elsevier Inc. (97)

More Publishers

Results (1328)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pan-cancer analysis of oncogenic MET fusions reveals distinct pathogenomic subsets with differential sensitivity to MET-targeted therapy
    Journal Article

    Febres-Aldana, C. A.; Vojnic, M.; Odintsov, I.; Zhang, T.; Cheng, R.; Beach, C. Z.; Lu, D.; Mattar, M. S.; Gazzo, A. M.; Gili, L.; more...
    Cancer Discovery (2025)

    Fulltext@MSK | Save
  • Higher proportion of frameshift mutations and tumor mutational burden in MLH1-deficient colorectal cancers with secondary alterations in MSH3 or MSH6
    Meeting Abstract

    Wang, J.; Yao, J. J.; Vakiani, E.; Weiser, M.; Stadler, Z.; Shia, J.; Ladanyi, M.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Integrin-linked kinase drives drug-tolerant persister cell survival and EMT in response to EGFR inhibition in lung adenocarcinoma
    Meeting Abstract

    Shi, R.; Farnsworth, D. A.; Febres-Aldana, C. A.; Chow, J. L. M.; Sheena, R.; Atwal, T.; Marti, J. L. G.; Thomas, K. N.; Lee, C. M.; Awrey, S. J.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • RRAS and RRAS2 hotspot mutations as novel actionable oncogenic drivers in lung adenocarcinoma
    Meeting Abstract

    Ladanyi, M.; Yang, S. R.; Zhang, T.; de Stanchina, E.; Somwar, R.
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Evaluating RNA sequencing as an alternative to IHC for HER2 expression in breast carcinoma
    Meeting Abstract

    Al-Othman, Y.; Gazzo, A.; Haque, M.; Ross, D.; Ladanyi, M.; Boroujeni, A. M.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Genetic ancestry-based differences in biomarker-based eligibility for precision oncology therapies
    Journal Article

    Arora, K.; Suehnholz, S. P.; Zhang, H.; Ostrovnaya, I.; Kundra, R.; Nandakumar, S.; Nissan, M. H.; Brannon, A. R.; Bandlamudi, C.; Ladanyi, M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Methylation analysis reveals epigenetic congruence between bone sarcomas with H3-3A mutations and malignant giant cell tumors of bone
    Journal Article

    Saoud, C.; Benhamida, J.; Borsu, L.; Villafania, L.; Linos, K.; Brannon, A. R.; Sinchun, H.; Morris, C.; Vaynrub, M.; Bartelstein, M.; more...
    Modern Pathology (2025)

    Fulltext@MSK | Save
  • Targeted RNA sequencing in diagnostically challenging head and neck carcinomas identifies novel MON2::STAT6, NFATC2::NUTM2B, POC5::RAF1, and NSD3::NCOA2 gene fusions
    Journal Article

    Chu, Y. H.; Katabi, N.; Sukhadia, P.; Mullaney, K. A.; Zaidinski, M.; Cracchiolo, J. R.; Xu, B.; Ghossein, R. A.; Ho, A. L.; DiNapoli, S. E.; more...
    Histopathology (2025)

    Fulltext@MSK | Save
  • Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer
    Journal Article

    Zucker, M.; Perry, M. A.; Gould, S. I.; Elkrief, A.; Safonov, A.; Thummalapalli, R.; Mehine, M.; Chakravarty, D.; Brannon, A. R.; Ladanyi, M.; more...
    Cell (2025)

    Fulltext@MSK | Save
  • Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors
    Journal Article

    Di Federico, A.; Hong, L.; Elkrief, A.; Thummalapalli, R.; Cooper, A. J.; Ricciuti, B.; Digumarthy, S.; Alessi, J. V.; Gogia, P.; Pecci, F.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save